Login
$ARDX
$3.09 +$0.02 (0.65%) After hours

$ARDX 8-K SEC Filings

Filed On Filing
03 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Q3 2026 total product revenue of $125.5 million, reflecting 19% growth year-over-year

17 Aug 2026 8-K: Other Events

On August 11, 2026, Eric Foster notified Ardelyx, Inc. (the “Company”) of his decision to resign as Chief Commercial Officer of the Company, effective August 28, 2026. Mr. Foster resigned to pursue a new opportunity with a pre-commercial...

06 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Q2 2026 total product revenue of $118.1 million, reflecting 31% growth year-over-year

02 Jul 2026 8-K: Creation of a Direct Financial Obligation

On June 29, 2026, Ardelyx, Inc. (the “Company”) received $50.0 million of funding (the “Term F Loan”) pursuant to the loan and security agreement entered into in February 2022 by and between the Company and SLR Investment Corp., as colla...

17 Jun 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

This Second Amendment (this “Amendment”) to the Ardelyx, Inc. Amended and Restated 2014 Equity Incentive Award Plan, as amended (the “Plan”), is made and adopted by the Board of Directors (the “Board”) of Ardelyx, Inc. (the “Company”), o...

30 Apr 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Q1 2026 total product revenue of $93.4 million, reflecting 38% growth year-over-year

19 Feb 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

IBSRELA revenue grew 73% in 2025 to $274.2 million and total revenues reached $407.3 million

08 Jan 2026 8-K: Results of Operations and Financial Condition; Other Events

On January 8, 2026, Ardelyx, Inc. (the “Company”) announced:

17 Dec 2025 8-K: Departure/Election of Directors or Officers; Compensation; Other Events

On December 17, 2025, Elizabeth Grammer informed Ardelyx, Inc. (the “Company”) of her resignation as the Company’s Chief Legal and Administrative Officer, effective December 31, 2025 (the “Resignation Date”).

30 Oct 2025 8-K: Results of Operations and Financial Condition

Q3 2025 product revenue of $105.5 million reflects 15% year-over-year growth

14 Oct 2025 8-K: Departure/Election of Directors or Officers; Compensation

On October 13, 2025, the board of directors (the “Board”) of Ardelyx, Inc. (the “Company”) appointed Sue Hohenleitner as chief financial officer (“CFO”) and principal financial officer, effective November 4, 2025.

04 Aug 2025 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more

The registered office of Ardelyx, Inc. (the “Corporation”) shall be fixed in the Corporation’s certificate of incorporation, as the same may be amended from time to time (the “certificate of incorporation”).

03 Jul 2025 8-K: Entry into a Material Definitive Agreement

THIS FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”) is entered into as of the date first written above, by and among SLR INVESTMENT CORP., a Maryland corporation with an office located at 500 Park Avenue, 3rd Floor, Ne...

18 Jun 2025 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

This First Amendment (this “Amendment”) to the Amended and Restated 2014 Equity Incentive Award Plan (the “Plan”), is made and adopted by the Board of Directors (the “Board”) of Ardelyx, Inc. (the “Company”), on April 29, 2025 (the “Adop...

01 May 2025 8-K: Results of Operations and Financial Condition

Company reports $74.1 million in Q1 total revenue, reflecting 61% growth year-over-year

29 Apr 2025 8-K: Departure/Election of Directors or Officers; Compensation

On April 28, 2025, the Company appointed Merdad Parsey, M.D., Ph.D, as a member of the Board of Directors (the “Board”) of Ardelyx, Inc., a Delaware corporation (the “Company”), effective immediately, to serve as a Class I director until...

20 Feb 2025 8-K: Results of Operations and Financial Condition

Company achieved significant commercial progress in 2024, finishing with total revenue of $333.6 million, including $319.2 million in U.S. Net Product Sales

13 Jan 2025 8-K: Results of Operations and Financial Condition; Other Events

On January 13, 2025, Ardelyx, Inc. (the “Company”) announced:

18 Nov 2024 8-K: Departure/Election of Directors or Officers; Compensation

The Company has appointed Joseph Reilly to replace Robert Felsch in his capacity as the Company’s Principal Accounting Officer effective November 15, 2024. Mr. Felsch will remain with the Company and will transition to a senior financial...

31 Oct 2024 8-K: Results of Operations and Financial Condition

IBSRELA generates $40.6 million in net product sales revenue; Company expects full year 2024 IBSRELA net sales revenue to be between $145 and $150 million

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support